Search Results - "Malkowicz, S B"
-
1
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Published in JAMA : the journal of the American Medical Association (16-09-1998)“…CONTEXT.— Interstitial radiation (implant) therapy is used to treat clinically localized adenocarcinoma of the prostate, but how it compares with other…”
Get full text
Journal Article -
2
Does Race Affect Postoperative Outcomes in Patients With Low-Risk Prostate Cancer Who Undergo Radical Prostatectomy?
Published in Urology (Ridgewood, N.J.) (01-03-2009)“…Objectives To assess the magnitude of racial disparities in prostate cancer outcomes following radical prostatectomy for low-risk prostate cancer. Methods We…”
Get full text
Journal Article -
3
Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
Published in JNCI : Journal of the National Cancer Institute (19-08-1998)“…Background: Pathways involved in androgen metabolism have been implicated in the etiology of prostate cancer. The goal of this study was to evaluate the effect…”
Get full text
Journal Article -
4
Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study
Published in The Journal of urology (01-01-2008)“…We evaluated the effects of toremifene on bone mineral density, a surrogate for fracture risk, in men receiving androgen deprivation therapy for prostate…”
Get more information
Journal Article -
5
Clinical Utility of the Percentage of Positive Prostate Biopsies in Defining Biochemical Outcome After Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer
Published in Journal of clinical oncology (01-03-2000)“…To determine the clinical utility of the percentage of positive prostate biopsies in predicting prostate-specific antigen (PSA) outcome after radical…”
Get full text
Journal Article -
6
Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate Cancer
Published in Journal of clinical oncology (01-01-1999)“…To present nomograms providing estimates of prostate-specific antigen (PSA) failure-free survival after radical prostatectomy (RP) or external-beam radiation…”
Get full text
Journal Article -
7
Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen
Published in Journal of clinical oncology (01-01-1998)“…To determine the toxicity and efficacy of an outpatient regimen of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium. Patients…”
Get more information
Journal Article -
8
The role of diethylstilbestrol in the treatment of prostate cancer
Published in Urology (Ridgewood, N.J.) (01-08-2001)“…Objectives: Diethylstilbestrol administration was a classic form of androgen deprivation therapy (ADT) that gradually fell out of favor because of its…”
Get full text
Journal Article -
9
A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer
Published in The Journal of urology (01-07-1995)“…A Cox regression multivariate analysis was done to determine the clinical and pathological indicators that predict for prostate specific antigen (PSA) failure…”
Get more information
Journal Article -
10
Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men
Published in Urology (Ridgewood, N.J.) (01-05-2003)“…To describe the clinical features of prostate cancer in Senegalese men and compare these features with those found in African-American and white American men…”
Get full text
Journal Article -
11
Preemptive Epidural Analgesia and Recovery From Radical Prostatectomy: A Randomized Controlled Trial
Published in JAMA : the journal of the American Medical Association (08-04-1998)“…CONTEXT.— Preemptive analgesia can decrease the sensitization of the central nervous system that would ordinarily amplify subsequent nociceptive input, but a…”
Get full text
Journal Article -
12
Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors
Published in International journal of cancer (20-01-2005)“…Genetic factors may be used not only to assess risk of prostate cancer development but also to evaluate prostate cancer outcomes including clinical prognosis,…”
Get full text
Journal Article -
13
Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer
Published in Urology (Ridgewood, N.J.) (01-04-2000)“…Objectives. Early (2 years or less) prostate-specific antigen (PSA) failure has been shown to predict for distant failure. The independent clinical predictors…”
Get full text
Journal Article -
14
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial
Published in Journal of clinical oncology (01-04-1997)“…A multivariable analysis to evaluate the potential clinical and pathologic factors that predict for early biochemical failure in patients with pathologically…”
Get more information
Journal Article -
15
Association of SRD5A2 genotype and pathological characteristics of prostate tumors
Published in Cancer research (Chicago, Ill.) (15-03-2000)“…The enzyme product of SRD5A2, 5alpha-reductase type II, is responsible for converting testosterone to the more metabolically active dihydrotestosterone…”
Get full text
Journal Article -
16
The application of human complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer
Published in Urologic clinics of North America (01-02-2000)“…The BTA TRAK assay is a quantitative sandwich format enzyme immunoassay performed in a reference laboratory. It measures levels of human complement factor…”
Get more information
Journal Article -
17
Erectile function and quality of life after interstitial radiation therapy for prostate cancer
Published in International journal of impotence research (01-09-2000)“…Few studies have evaluated erectile function after interstitial radiation therapy for localized prostate cancer. Using a validated quality of life…”
Get full text
Conference Proceeding Journal Article -
18
Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer
Published in Journal of clinical oncology (01-06-1996)“…To determine whether there is a role for endorectal coil magnetic resonance imaging (erMRI) in the prediction of pathologic stage, margin status, and/or…”
Get more information
Journal Article -
19
Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4
Published in Human heredity (01-01-2002)“…Ethnic differences in prostate cancer incidence are well documented, with African-Americans having among the highest rates in the world. Ethnic differences in…”
Get more information
Journal Article -
20
Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease
Published in Urology (Ridgewood, N.J.) (01-03-1998)“…Objectives. Endorectal coil magnetic resonance imaging (erMRI) has been reported to improve the prediction of pathologic Stage T3 disease in patients with…”
Get full text
Journal Article